 Connection
Jennifer Kiser to Tuberculosis
This is a "connection" page, showing publications Jennifer Kiser has written about Tuberculosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.490 |
|
|
|
-
Kiser JJ, Zhu R, D'Argenio DZ, Cotton MF, Bobat R, McSherry GD, Madhi SA, Carey VJ, Seifart HI, Werely CJ, Fletcher CV. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Ther Drug Monit. 2012 Aug; 34(4):446-51.
Score: 0.288
-
Béranger A, Solans BP, Miyakawa R, McIlleron H, Tarning J, Shah I, Aruldhas BW, Mathew BS, Kwara A, Peloquin CA, Mukherjee A, Lodha R, Denti P, Capparelli EV, Kiser JJ, Bekker A, Chabala C, Choo L, Turkova A, Gafar F, Ruslami R, Nataprawira HM, Heysell SK, Thomas TA, Velpandian T, Day JN, Bang ND, Dooley K, Savic RM. Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis. Eur Respir J. 2026 Mar; 67(3).
Score: 0.185
-
Zhu R, Kiser JJ, Seifart HI, Werely CJ, Mitchell CD, D'Argenio DZ, Fletcher CV. The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid. J Clin Pharmacol. 2012 Apr; 52(4):511-9.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|